BNTX · Categories · Form 4
BNTX - SEC Form 4 insider transactions
BioNTech SE (BNTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for BNTX
- SEC Form 4 filed by BioNTech SE4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by BioNTech SE4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $3,301,068 worth of Ordinary Shares (34,000 units at $97.09) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 180,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $6,480,659 worth of Ordinary Shares (66,000 units at $98.19) as part of a pre-agreed trading plan, decreasing direct ownership by 24% to 214,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $6,012,500 worth of Ordinary Shares (61,000 units at $98.57) as part of a pre-agreed trading plan, decreasing direct ownership by 18% to 280,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $6,842,742 worth of Ordinary Shares (69,000 units at $99.17) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 341,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $7,860,757 worth of Ordinary Shares (79,000 units at $99.50) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 410,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $6,239,071 worth of Ordinary Shares (64,000 units at $97.49) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 489,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $4,721,976 worth of Ordinary Shares (49,000 units at $96.37) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 553,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $8,439,336 worth of Ordinary Shares (86,000 units at $98.13) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 602,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $1,974,287 worth of Ordinary Shares (20,500 units at $96.31) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 688,209 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $7,190,663 worth of Ordinary Shares (73,000 units at $98.50) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 708,709 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- Chief Executive Officer Sahin Ugur sold $7,889,055 worth of Ordinary Shares (76,500 units at $103.12) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 781,709 units (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Zapata Gomez Ramon4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Officer Ryan James Timothy Patrick4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Poetting Sierk4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief People Officer Jimenez Kylie4 - BioNTech SE (0001776985) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Hanekamp Annemarie4 - BioNTech SE (0001776985) (Issuer)
- Chief Operating Officer Poetting Sierk sold $5,527,960 worth of Ordinary Shares (50,000 units at $110.56) (SEC Form 4)4 - BioNTech SE (0001776985) (Issuer)